Vecuronium bromide cas no:50700-72-6
Synonyms: [(3S,5S,8R,9S,10S,13S,14S)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide;[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide;Piperidinium,1-[(2a,3R,5R,16a,17a)-3,17-bis- (acetyloxy)-2-(1-piperidinyl)androstan-16- yl]-1-methyl-,bromide;Vecuronium bromide (JAN/USAN);Vecoronium Bromide;Org-NC 45;Norcuron;Norcuron (TN);Vecuronium;16β-PIPECOLINIO-2β-PIPERIDINO-5α-ANDROSTAN-3α,17β-DIOL BROMIDE DIACETATE;ORG NC 45;VercuroniumBromide;Vecuronium Bromide CAS 50700-72-6;VECURONIUM BROMIDE,99%;Vecuromium bromide;Vencuronium;? Vecuronium bromide;
NameVecuronium bromide
CAS50700-72-6
Synonyms[(3S,5S,8R,9S,10S,13S,14S)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide;[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide;Piperidinium,1-[(2a,3R,5R,16a,17a)-3,17-bis- (acetyloxy)-2-(1-piperidinyl)androstan-16- yl]-1-methyl-,bromide;Vecuronium bromide (JAN/USAN);Vecoronium Bromide;Org-NC 45;Norcuron;Norcuron (TN);Vecuronium;16β-PIPECOLINIO-2β-PIPERIDINO-5α-ANDROSTAN-3α,17β-DIOL BROMIDE DIACETATE;ORG NC 45;VercuroniumBromide;Vecuronium Bromide CAS 50700-72-6;VECURONIUM BROMIDE,99%;Vecuromium bromide;Vencuronium;? Vecuronium bromide;
EINECS(EC#)256-723-9
Molecular FormulaC34H57BrN2O4
Molecular Weight637.74
Appearancewhite powder
storage tempStore in original container in a cool dark place.
Hazard Xi: Irritant;
Risk R36/37/38
Safety
Hazard Codes:?
Xi
Risk Statements: 36/37/38?
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-37/39?
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.?
S37/39:Wear suitable gloves and eye/face protection.
Poison by ingestion, subcutaneous, intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx and Br?.
| 1. |
??? |
orl-rat LD50:455?mg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 2. |
??? |
ipr-rat LD50:2630?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 3. |
??? |
scu-rat LD50:1730?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 4. |
??? |
ivn-rat LD50:200?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 5. |
??? |
orl-mus LD50:41?mg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 6. |
??? |
ipr-mus LD50:144?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 7. |
??? |
scu-mus LD50:148?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
| 8. |
??? |
ivn-mus LD50:51?μg/kg
|
??? |
KSRNAM ?? Kiso to Rinsho. Clinical Report. 20 (1986),807. |
